30. Lapchak P. A. and Hefti F. (1992) BDNF and NGF treatment in lesioned rats: eVects on cholinergic function and
weight gain. NeuroReport 3, 405–408.
31. Lapchak P. A. and Araujo D. M. (1994) NGF suppression of weight gain in adult female rats correlates with decreased
hypothalamic cholecystokinin levels. Brain Res. 655, 12–16.
32. Lapchak P. A., Beck K. D., Araujo D. M., Irwin I., Langston J. W. and Hefti F. (1993) Chronic intranigral
administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult
rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Neuroscience 53, 639–650.
33. Lapchak P. A., Collins F., Gash D., HoVer B., Gerhardt G., Jiao S., Miller P. J., Ovadia A. and Zhang Z. (1996)
Distribution of 125I-GDNF in the rat and primate CNS following an icv injection: correlation with the behavioral and
pharmacological activities of icv administered GDNF in Parkinson's disease models. ASNT P52.
34. Lapchak P. A., Jiao S., Miller P. J., Williams L., Cummins V., Inouye G., Matheson C. R. and Yan Q. (1996)
Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a
therapeutic molecule to treat neurodegenerative diseases. Cell Tiss. Res. 286, 179–189.
34a. Lapchak P. A., Miller P. J., Jiao S., Araujo D. M., Hilt D. and Collins F. (1996) Biology of glial cell line-derived
neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease. Neurodegeneration 5,
197–205.
35. Lin L. H., Doherty D. H., Lile J. D., Bektesh S. and Collins F. (1993) GDNF: A glial cell line-derived neurotrophic
factor for midbrain dopaminergic neurons. Science 260, 1130–1132.
36. Luine V. N., Renner K. J., Heady S. and Jones K. J. (1986) Age and sex-dependent decrease in ChAT in basal
forebrain nuclei. Neurobiol. Agng 7, 193–198.
37. Martin D., Miller G., Fischer N., Dix D. and Cullen T. (1996) Glial derived neurotrophic factor: the lateral cerebral
ventricle is an eVective site of administration for stimulation of the nigrostriatal system. Eur. J. Neurosci 8, 1249–1255.
38. Miller R. and Beninger R. J. (1991) On the interpretation of asymmetries of posture and locomotion produced with
dopamine agonists in animals with unilateral depletion of striatal dopamine. Prog. Neurobiol. 36, 229–256.
39. Nakamura S. and Ohno T. (1995) Spatial learning impairment in aged rats: comparing between aged basal forebrain
lesioned and normal aged rats. Behav. Brain Res. 70, 69–76.
40. Ogawa N., Asanuma M., Kondo Y., Nishibayashi S. and Mori A. (1994) Reduced choline acetyltransferase activity
and muscarine M1 receptor levels in aged Fisher 344 rat brains did not parallel their respective mRNA levels. Brain
Res. 658, 87–92.
41. Olson L. (1993) NGF and the treatment of Alzheimer's disease. Expl Neurol. 124, 5–15.
42. Reinhard J. F. Jr., Smith G. K. and Nichol C. A. (1986) A rapid and sensitive assay for tyrosine-3-monooxygenase
based upon the release of 3H O and absorption of [3H]tyrosine by charcoal. Life Sci. 39, 2185–2189.
2

43. Rylett R. J., Goddard S., Schmidt S. M. and Williams L. R. (1993) Acetylcholine synthesis and release following
continous intracerebral administration of NGF in adult and aged Fisher-344 rats. J. Neurosci. 13, 3956–3963.
44. Sastry R. B. V., Janson V. E., Jaiswal N. and Tayeb O. S. (1983) Changes in enzymes of the cholinergic system and
acetylcholine release in the cerebra of aging male Fischer rats. Pharmacology 26, 61–72.
45. Shults C. W., Shinm C., Ernestom C. and Martin D. (1996) EVects of intrastriatal injections of glial cell line-derived
neurotrophic factor (GDNF) in rats. Expl Neurol. (in press).
46. Stoessl A. J., Martin-Iverson M. T., Barth T. M., Dourish C. T. and Iversen S. D. (1989) EVects of ageing on the
behavioral responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy. Brain Res.
495, 20–30.
47. Tomac A., Widenfalk J., Lin L. F. H., Kohno T., Ebendal T., HoVer B. J. and Olson L. (1995) Retrograde axonal
transport of GDNF in the adult nigro-striatal system suggests a trophic role in the adult. Proc. natn. Acad. Sci. U.S.A.
92, 8274–8278.
48. Walter S. B. and London E. (1989) Choline acetyltransferase activity and muscarinic binding in brain regions of aging
Fischer 344 rats. Neurochem. Int. 14, 483–490.
49. Williams L. R. and Rylett R. J. (1990) Exogenous nerve growth factor increases the activity of high-aYnity choline
uptake and choline acetyltransferase in brain of Fisher 344 male rats. J. Neurochem. 55, 1042–1049.
50. Williams L. R. (1991) Hypophagia is induced by intraventricular administration of nerve growth factor. Expl Neurol.
113, 31–37.
51. Williams L. R., Inouye G., Cummins V. and Pelleymounter M. A. (1996) Glial cell line-derived neurotrophic factor
sustains axotomized basal forebrain cholinergic neurons in vivo: dose–response comparison to nerve growth factor and
brain-derived neurotrophic factor. J. Pharmac. exp. Ther. 277, 1140–1151.
